A Randomized, Open-label Study of the Effect of PEGASYS Combined With Ribavirin on Sustained Virologic Response in Patients With Chronic Hepatitis C Who Did Not Respond to Previous Pegintron/Ribavirin Combination Therapy
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms REPEAT
- Sponsors Roche
- 05 Nov 2011 Results presented at the 14th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
- 26 Apr 2009 Post-hoc analysis reported at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL).
- 21 Apr 2009 Full results published in Annals of Internal Medicine, 2009.